An extractor of oils from cannabis. They have the ability to move beyond CBD and THC extraction, into more of a pharmaceutical oil. They have long term contracts. There is some concern they are charging high premiums for extraction, so their margins may shrink in the future. This is not likely to harm them for the next five year, he thinks. A good cash flow producing stock in this space.
Medipharm Labs Corp is a Canadian stock, trading under the symbol LABS-T on the Toronto Stock Exchange (LABS-CT). It is usually referred to as TSX:LABS or LABS-T
In the last year, there was no coverage of Medipharm Labs Corp published on Stockchase.
Medipharm Labs Corp was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Medipharm Labs Corp.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
0 stock analysts on Stockchase covered Medipharm Labs Corp In the last year. It is a trending stock that is worth watching.
On 2024-12-20, Medipharm Labs Corp (LABS-T) stock closed at a price of $0.065.